11 2024 Blitz: Big Pharma, AstraZeneca wächst um 19 %, Bayer verlangsamt sich 1 Minuten vor Vodafone: Umsatz steigt, Prognose trotz Schwierigkeiten in Deutschland bestätigt 30 Minuten vor Iveco, ...

Von Helena Smolak DOW JONES--Astrazeneca plant weitere Investitionen von 2 Milliarden US-Dollar in den USA. Damit ist der Pharmakonzern eines ...

Die wichtigsten europäischen Börsen haben nach dem starken Wochenauftakt am Dienstag wieder etwas nach unten korrigiert.

CAMBRIDGE, England--(BUSINESS WIRE)--AstraZeneca today announces $3.5 billion of capital investment in the United States focused on expanding the Company’s research and manufacturing footprint by the ...

LONDON, Nov 6 (Reuters) - AstraZeneca (AZN.L), opens new tab said on Wednesday its China president Leon Wang had been detained by Chinese authorities and, although it did not know the reason ...

The executive in charge of AstraZeneca operations in China is under detention by Chinese authorities who are investigating employees there, the company said. The disclosure comes after AstraZeneca ...

Over the past three years, additional insurance fraud cases have emerged involving AstraZeneca employees in various Chinese regions. The investigation focuses on potential breaches of data privacy ...

AstraZeneca Plc said its experimental obesity pill was well tolerated by patients with type-2 diabetes as it presented data from several studies testing its three new weight-loss medicines. The ...

AstraZeneca Says Current, Former Executives Involved in China Probe The company’s China president has been detained by authorities Astra has attempted to quell concerns over the investigation ...

Nov 5 (Reuters) - AstraZeneca (AZN.L), opens new tab shares on Tuesday recorded their worst day since March 2020 after a report that dozens of the drugmaker's senior executives in China could be ...

AstraZeneca may be emphasizing the potential for combination treatments to help its obesity pipeline stand out from the crowd, but the Big Pharma insists it is still “playing to win” in the space.

In its presentation at ObesityWeek 2024 meeting in Texas, the multinational drug company AstraZeneca (NASDAQ:AZN) revealed positive initial clinical trial results for its obesity drug candidate ...